Dear folks,
was the new drug for Arthritis pain by Merck Company rejected by the US-Food & Drug?
sarah
It appears so. The FDA advisory panel voted no because it didn't show significant improvement over existing therapies and it poses cardiac risks. Here's a link to one article:
http://www.nj.com/business/ledger/index.ssf?/base/business-0 /117644462497130.xml&coll=1
I read that yesterday. I told my husband I just want my Vioxx back...forget the new stuff! Although it would be my luck to get a heart attck once I restarted it. I was on it for 6 years, I think, without any problems.Dear Shandi, interesting comment you just made about Vioxx, as I took that drug several years ago. I have just had a heart problem which the docs say was 'inherited', so do we know? This is all a mystery, isn't it?!
sarah